Logo image of PFE

PFIZER INC (PFE) Stock Price, Quote, News and Overview

NYSE:PFE - New York Stock Exchange, Inc. - US7170811035 - Common Stock - Currency: USD

24.2  +0.27 (+1.13%)

After market: 24.18 -0.02 (-0.08%)

PFE Quote, Performance and Key Statistics

PFIZER INC

NYSE:PFE (5/2/2025, 10:11:47 PM)

After market: 24.18 -0.02 (-0.08%)

24.2

+0.27 (+1.13%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High31.54
52 Week Low20.92
Market Cap137.25B
Shares5.67B
Float5.67B
Yearly Dividend1.68
Dividend Yield7.19%
PE7.54
Fwd PE7.9
Earnings (Next)07-28 2025-07-28/bmo
IPO01-17 1944-01-17


PFE short term performance overview.The bars show the price performance of PFE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10

PFE long term performance overview.The bars show the price performance of PFE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of PFE is 24.2 USD. In the past month the price decreased by -0.37%. In the past year, price decreased by -12.98%.

PFIZER INC / PFE Daily stock chart

PFE Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 59.86 780.78B
JNJ JOHNSON & JOHNSON 15.53 375.64B
NVO NOVO-NORDISK A/S-SPONS ADR 20.07 307.32B
NVS NOVARTIS AG-SPONSORED ADR 13.75 225.73B
AZN ASTRAZENECA PLC-SPONS ADR 19.47 224.59B
MRK MERCK & CO. INC. 10.68 209.31B
SNY SANOFI-ADR 14.4 135.72B
BMY BRISTOL-MYERS SQUIBB CO 6.89 102.91B
GSK GSK PLC-SPON ADR 7.16 79.05B
ZTS ZOETIS INC 26.59 70.23B
HLN HALEON PLC-ADR 22.29 48.25B
TAK TAKEDA PHARMACEUTIC-SP ADR 33.3 48.22B

About PFE

Company Profile

PFE logo image Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The company is headquartered in New York City, New York and currently employs 81,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.

Company Info

PFIZER INC

66 Hudson Boulevard East

New York City NEW YORK 10017 US

CEO: Albert Bourla

Employees: 81000

PFE Company Website

PFE Investor Relations

Phone: 12127332323

PFIZER INC / PFE FAQ

What is the stock price of PFIZER INC today?

The current stock price of PFE is 24.2 USD. The price increased by 1.13% in the last trading session.


What is the ticker symbol for PFIZER INC stock?

The exchange symbol of PFIZER INC is PFE and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is PFE stock listed?

PFE stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for PFIZER INC stock?

28 analysts have analysed PFE and the average price target is 29.71 USD. This implies a price increase of 22.77% is expected in the next year compared to the current price of 24.2. Check the PFIZER INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is PFIZER INC worth?

PFIZER INC (PFE) has a market capitalization of 137.25B USD. This makes PFE a Large Cap stock.


How many employees does PFIZER INC have?

PFIZER INC (PFE) currently has 81000 employees.


What are the support and resistance levels for PFIZER INC (PFE) stock?

PFIZER INC (PFE) has a support level at 21.91 and a resistance level at 25.39. Check the full technical report for a detailed analysis of PFE support and resistance levels.


Is PFIZER INC (PFE) expected to grow?

The Revenue of PFIZER INC (PFE) is expected to decline by -0.2% in the next year. Check the estimates tab for more information on the PFE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy PFIZER INC (PFE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PFIZER INC (PFE) stock pay dividends?

PFIZER INC (PFE) has a dividend yield of 7.19%. The yearly dividend amount is currently 1.68. Check the full fundamental report for a detailed analysis of PFE dividend history, reliability and sustainability.


When does PFIZER INC (PFE) report earnings?

PFIZER INC (PFE) will report earnings on 2025-07-28, before the market open.


What is the Price/Earnings (PE) ratio of PFIZER INC (PFE)?

The PE ratio for PFIZER INC (PFE) is 7.54. This is based on the reported non-GAAP earnings per share of 3.21 and the current share price of 24.2 USD. Check the full fundamental report for a full analysis of the valuation metrics for PFE.


What is the Short Interest ratio of PFIZER INC (PFE) stock?

The outstanding short interest for PFIZER INC (PFE) is 1.9% of its float. Check the ownership tab for more information on the PFE short interest.


PFE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to PFE. When comparing the yearly performance of all stocks, PFE is a bad performer in the overall market: 70.29% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PFE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to PFE. While PFE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PFE Financial Highlights

Over the last trailing twelve months PFE reported a non-GAAP Earnings per Share(EPS) of 3.21. The EPS increased by 126.06% compared to the year before.


Industry RankSector Rank
PM (TTM) 12.62%
ROA 3.76%
ROE 9.11%
Debt/Equity 0.69
Chartmill High Growth Momentum
EPS Q2Q%12.2%
Sales Q2Q%-7.82%
EPS 1Y (TTM)126.06%
Revenue 1Y (TTM)11.65%

PFE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 70% to PFE. The Buy consensus is the average rating of analysts ratings from 28 analysts.

For the next year, analysts expect an EPS growth of -3.97% and a revenue growth -0.2% for PFE


Ownership
Inst Owners67.49%
Ins Owners0.02%
Short Float %1.9%
Short Ratio2.01
Analysts
Analysts70
Price Target29.71 (22.77%)
EPS Next Y-3.97%
Revenue Next Year-0.2%